Polypharmacy and drug persistence - patient perspective

31 August 2026 (13:36 - 13:48)

Organised by:

About the speaker

Doctor Mattias Van Heetvelde

ESC Patient Forum, Gent (Belgium)

4 More presentations in this session

Presentation thumbnail

Global medication safety and polypharmacy: a World Health Organization perspective

Professor G. Parati (Milan, IT)

Presentation thumbnail

Polypharmacy and deprescribing: integrating age and comorbidity

Doctor M. Blanquet (Clermont-Ferrand, FR)

Presentation thumbnail

Artificial intelligence for managing polypharmacy: from prediction to clinical decision support

Professor T. Grodzicki (Cracow, PL)

Presentation thumbnail

Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation - discussion

Access the full session

Session thumbnail

Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation

The Event

Event poster

ESC Congress 2026

31 August 2026 13:36 CET

You may be interested in

Congress Presentation

Persistence to guideline-based therapy newly prescribed after a hospitalization for heart failure. Data from two large cohorts in the US and Germany.

20 May 2023

Congress Presentation

Dangers of polypharmacy: how to identify and how to limit the risk

4 April 2025

Congress Presentation

An observational, international, cohort study to evaluate the satisfaction and preferences of patients in preventive treatment of secondary cardiovascular events with a cardiovascular polypill

3 September 2019

Congress Presentation

Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

26 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources